Jump to content

tolvaptan (Q426132)

From Wikidata
selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone
  • OPC-41061
  • Samsca®
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    tolvaptan
    selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone
    • OPC-41061
    • Samsca®

    Statements

    0 references
    C₂₆H₂₅ClN₂O₃
    1 reference
    CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C
    1 reference
    1 reference
    FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
    448.155 dalton
    1 reference
    Tolvaptan
    0 references

    Identifiers

    1 reference
    28 October 2019
    Tolvaptan (English)
    10 May 2021
    1 reference
    27 December 2018
    N-(4-{[(5S)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}-3-methylphenyl)-2-methylbenzamide (English)
    CAS no.: 150683-30-0 (English)
    1 reference
    27 December 2018
    N-(4-{[(5S)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}-3-methylphenyl)-2-methylbenzamide (English)
    CAS no.: 150683-30-0 (English)
    0 references
     
    edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit